Showing 181-200 of 746 for: Cochrane Systematic Reviews > Pharmacotherapeutics 
- Calcium channel blockers for potential impaired fetal growth
Cochrane Systematic Reviews, 22-Apr-1996
Calcium channel blockers may increase the blood flow to the fetus or may improve fetal-placental cellular energy generation. This could enhance fetal growth.
- Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients
Cochrane Systematic Reviews, 17-Oct-2007
The incidence of delayed graft function in cadaveric grafts has increased over the last few years due in part to the large demand for cadaveric kidneys necessitating the use of kidneys from marginal donors. Calcium channel blockers have the potential to r
- Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Cochrane Systematic Reviews, 1-Oct-2018
Pre-eclampsia and eclampsia are common causes of serious morbidity and death. Calcium supplementation may reduce the risk of pre-eclampsia, and may help to prevent preterm birth. This is an update of a review last published in 2014.
- Calcium supplementation for improving bone mineral density in children
Cochrane Systematic Reviews, 16-Mar-2010
Clinical trials have shown that calcium supplementation in children can increase bone mineral density (BMD) although this effect may not be maintained. There has been no quantitative systematic review of this intervention.
- Calcium supplementation for the management of primary hypertension in adults
Cochrane Systematic Reviews, 19-Apr-2006
Metabolic studies suggest calcium may have a role in the regulation of blood pressure. Some epidemiological studies reported people with a higher intake of calcium tend to have lower blood pressure. Previous systematic reviews and meta-analyses reached co
- Carbamazepine for chronic neuropathic pain and fibromyalgia in adults
Cochrane Systematic Reviews, 10-Apr-2014
This is an update of a Cochrane review entitled 'Carbamazepine for acute and chronic pain in adults' published in Issue 1, 2011. Some antiepileptic medicines have a place in the treatment of neuropathic pain (pain due to nerve damage). This updated review
- Carbamazepine for schizophrenia
Cochrane Systematic Reviews, 2-May-2014
Many people with schizophrenia do not achieve a satisfactory treatment response with just antipsychotic drug treatment and various adjunct medications are used to promote additional response. The antiepileptic carbamazepine is one such drug.
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 19-Oct-2005
Beta-blocker therapy has a proven mortality benefit in patients with hypertension, heart failure and coronary artery disease, as well as during the perioperative period. These drugs have traditionally been considered contraindicated in patients with chron
- Cardioselective beta‐blockers for reversible airway disease
Cochrane Systematic Reviews, 21-Oct-2002
Beta-blocker therapy has mortality benefit in patients with hypertension, heart failure and coronary artery disease, as well as during the perioperative period. These drugs have traditionally been considered contraindicated in patients with reversible air
- Celecoxib for rheumatoid arthritis
Cochrane Systematic Reviews, 9-Jun-2017
Rheumatoid arthritis (RA) is a systemic auto-immune disorder, involving persistent joint inflammation. NSAIDs are used to control the symptoms of RA, but are associated with significant gastro-intestinal toxicity, including a risk of potentially life thre
- Central action beta‐blockers versus placebo for neuroleptic‐induced acute akathisia
Cochrane Systematic Reviews, 18-Oct-2004
Neuroleptic-induced akathisia is a common, distressing early-onset adverse effect of neuroleptic drugs. It has been associated with poor treatment compliance and an increased risk of relapse.
- Central venous access sites for the prevention of venous thrombosis, stenosis and infection
Cochrane Systematic Reviews, 14-Mar-2012
Central venous access (CVA) is widely used. However, its thrombotic, stenotic and infectious complications can be life-threatening and involve high-cost therapy. Research revealed that the risk of catheter-related complications varied according to the sit
- Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
Cochrane Systematic Reviews, 22-Apr-2003
Both chemotherapy and endocrine therapy can be used as treatments for metastatic breast cancer.
- Chemotherapy for advanced ovarian cancer
Cochrane Systematic Reviews, 25-Jan-1999
Ovarian carcinoma is the seventh commonest female cancer worldwide and is responsible for the greatest number of deaths from gynaecological malignancy in Europe and North America. Although many studies have explored the use of chemotherapy in this disease
- Chemotherapy for high‐grade glioma
Cochrane Systematic Reviews, 21-Oct-2002
Trials on the effect of systemic chemotherapy on survival and recurrence in adults with high-grade glioma have had inconclusive results. We undertook a systematic review and meta-analysis to assess the effects of such treatment on survival and recurrence.
- Chemotherapy versus best supportive care for extensive small cell lung cancer
Cochrane Systematic Reviews, 22-Nov-2013
Combination chemotherapy has been the mainstay of treatment for extensive stage small celI lung cancer (SCLC) over the last 30 years, even though it only gives a short prolongation in median survival time. The main goal for these patients should be pallia
- Chinese herbal medicine for schizophrenia
Cochrane Systematic Reviews, 19-Oct-2005
Traditional Chinese medicine (TCM) was the main form of treatment in China for psychiatric illnesses until the development of antipsychotic drugs in the 1950's. Antipsychotic drugs have become the primary intervention for schizophrenia, although herbal me
- Chinese herbal medicine in the treatment of ectopic pregnancy
Cochrane Systematic Reviews, 6-Jul-2011
Traditionally Chinese herbal medicine (CHM) has been used widely in Chinese hospitals to treat ectopic pregnancy. Many studies have been published supporting its use but the evidence has not been systematically reviewed. This is and update of the review p
- Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection
Cochrane Systematic Reviews, 23-Apr-2001
About 350 million people are chronically infected carriers of hepatitis B virus and are at a higher risk of serious illness and death from cirrhosis of the liver and liver cancer. Chinese medicinal herbs have been used widely for more than 2000 years to t
- Chinese medicinal herbs for influenza
Cochrane Systematic Reviews, 28-Mar-2013
Influenza is a communicable acute respiratory infection which, during epidemics, can cause high morbidity and mortality rates. Traditional Chinese medicinal herbs, often administered following a particular Chinese medical theory, may be a potential treatm
